Evidence map›Paper›PMID 17437533›Full record

ReviewImmunology2007

BAC to immunology--bacterial artificial chromosome-mediated transgenesis for targeting of immune cells.

Tim Sparwasser, Gérard Eberl

Open access · bronzeAbstract readReview
In one paragraph

Review in Immunology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. RNA recognition by human TLR8 can lead to autoimmune inflammation.The Journal of experimental medicine · 2013
    Article
  7. Article
  8. Article
  9. In vivo analysis of mouse gastrin gene regulation in enhanced GFP-BAC transgenic mice.American journal of physiology. Gastrointestinal and liver physiology · 2011
    Article
  10. Article
  11. Review
  12. Article
  13. A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression and alters disease outcome.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Tim SparwasserInstitut für Medizinische Mikrobiologie, Immunologie & Hygiene, Technische Universität München, Munich, Germany. tim.sparwasser@lrz.tum.de
Gérard Eberl
Institut Pasteur · FRTechnical University of Munich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thirty years after the first transgenic mouse was produced, a plethora of genetic tools has been developed to study immune cells in vivo. A powerful development is the bacterial artificial chromosome (BAC) transgenic approach, combining advantages of both conventional transgenic and knock-in gene-targeting strategies. In immunology the potential of BAC transgenic technology has yet to be fully harvested and, combined with a variety of elegant genetic tools, it will allow the analysis of complex immunological processes in vivo. In this short review, we discuss the applications of BACs in immunology, such as identification of regulatory regions, expression and cell-fate mapping, cell ablation, conditional mutations and the generation of humanized mice.

Indexed as

Gene Transfer TechniquesAnimalsChromosomes, Artificial, BacterialDisease Models, AnimalGene TargetingMiceMice, Transgenic

Identifiers

PMID17437533
PMCPMC2265958
OpenAlexW2093878219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.